Loading clinical trials...
Loading clinical trials...
A Randomized Trial of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery (NEWTON-CABG)
Conditions
Interventions
Evolocumab
Placebo
Locations
22
United States
San Francisco VA Medical Center
San Francisco, California, United States
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
Maine Medical Center
Portland, Maine, United States
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, United States
University Hospital Cleveland Medical Center
Cleveland, Ohio, United States
Royal Adelaide Hospital
Adelaide, Australia
Start Date
May 30, 2019
Primary Completion Date
January 30, 2025
Completion Date
January 30, 2025
Last Updated
August 29, 2025
NCT01399385
NCT00353782
NCT01143454
NCT07241390
NCT05316311
NCT02932176
Lead Sponsor
Unity Health Toronto
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions